1. Home
  2. KB vs EW Comparison

KB vs EW Comparison

Compare KB & EW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KB Financial Group Inc

KB

KB Financial Group Inc

HOLD

Current Price

$120.93

Market Cap

42.2B

Sector

Finance

ML Signal

HOLD

Logo Edwards Lifesciences Corporation

EW

Edwards Lifesciences Corporation

HOLD

Current Price

$92.07

Market Cap

48.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KB
EW
Founded
2008
1958
Country
South Korea
United States
Employees
N/A
N/A
Industry
Commercial Banks
Industrial Specialties
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
42.2B
48.9B
IPO Year
2008
1999

Fundamental Metrics

Financial Performance
Metric
KB
EW
Price
$120.93
$92.07
Analyst Decision
Buy
Analyst Count
0
21
Target Price
N/A
$96.37
AVG Volume (30 Days)
253.9K
5.0M
Earning Date
04-23-2026
04-23-2026
Dividend Yield
2.31%
N/A
EPS Growth
N/A
N/A
EPS
N/A
1.07
Revenue
N/A
$6,067,600,000.00
Revenue This Year
$18.22
$13.39
Revenue Next Year
$3.21
$9.81
P/E Ratio
$9.90
$83.85
Revenue Growth
N/A
11.55
52 Week Low
$76.31
$72.30
52 Week High
$125.66
$96.29

Technical Indicators

Market Signals
Indicator
KB
EW
Relative Strength Index (RSI) 55.51 64.12
Support Level $113.10 $81.88
Resistance Level $125.62 $96.29
Average True Range (ATR) 2.40 2.54
MACD -0.04 0.69
Stochastic Oscillator 66.59 93.61

Price Performance

Historical Comparison
KB
EW

About KB KB Financial Group Inc

KB Financial Group Inc. is a financial holding company in Korea. The company operations include Kookmin Bank, one of the commercial banks in Korea. The company's subsidiaries collectively engage in a broad range of businesses, including commercial banking, credit cards, asset management, non-life and life insurance, capital markets activities, and international banking and finance. The company's segments include the Banking business, Securities business, Non-life Insurance business, Credit card business, and Life Insurance business. The Group generates the majority of its revenue from the Banking business.

About EW Edwards Lifesciences Corporation

Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.

Share on Social Networks: